Indraprastha Medical Corporation Ltd

AI

Indraprastha Medical Corporation Ltd

₹
- close price
About

Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]

Key Points

Parentage[1] [2] [3]
The company was incorporated as a joint venture between Apollo Hospitals Enterprise Ltd. (AHEL) and the Government of Delhi. As of Jun 2026, AHEL holds a 22% stake, while the Delhi Government holds a 26% stake in the company. Apollo Hospitals is a leading healthcare player that owns and operates the largest hospital chain in the country. Its network spans over 78 hospitals, 7,289 pharmacies, 2,501 diagnostic centres, more than 300 clinics and over 200 telemedicine centres

  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value ₹

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2023 (S) Dec 2023 (S) Mar 2024 (S) Jun 2024 (S) Sep 2024 (S) Dec 2024 (S) Mar 2025 (S) Jun 2025 (S) Sep 2025 (S) Dec 2025 (S) Mar 2026 (S) Jun 2026 (S) Sep 2026 (S)
317 306 315 348 350 325 334 365 381 372 365 406 413
267 259 266 281 286 273 272 292 310 310 304 326 335
Operating Profit 50 47 48 67 64 52 61 73 71 62 61 80 77
OPM % 16% 15% 15% 19% 18% 16% 18% 20% 19% 17% 17% 20% 19%
4 4 5 5 6 5 6 7 7 7 7 8 9
Interest 1 1 2 2 2 2 1 2 2 1 1 2 2
Depreciation 10 10 10 11 11 11 11 10 11 11 11 12 12
Profit before tax 44 41 42 60 57 45 55 68 66 56 55 75 72
Tax % 25% 28% 25% 25% 26% 26% 26% 25% 25% 27% 24% 25% 26%
33 29 31 45 42 33 41 51 49 41 42 56 54
EPS in Rs 3.58 3.21 3.40 4.88 4.63 3.58 4.47 5.61 5.40 4.47 4.55 6.09 5.84
Raw PDF

(S): Standalone figures, shown where consolidated figures are not available.

Profit & Loss

Figures in Rs. Crores

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
714 755 766 753 788 831 613 888 1,099 1,245 1,356 1,483
630 675 686 678 706 743 572 768 947 1,050 1,112 1,215
Operating Profit 85 80 79 74 82 87 41 120 152 195 245 267
OPM % 12% 11% 10% 10% 10% 11% 7% 14% 14% 16% 18% 18%
1 1 -0 -1 -1 -0 -0 -3 9 16 22 28
Interest 8 7 8 9 7 6 3 3 4 4 6 6
Depreciation 28 35 31 31 30 33 33 35 39 40 44 44
Profit before tax 50 39 41 34 45 48 4 79 117 166 216 246
Tax % 34% 37% 36% 38% 36% 9% 46% 26% 26% 25% 26% 25%
32 24 26 21 28 44 2 59 86 124 161 184
EPS in Rs 3.54 2.66 2.86 2.30 3.10 4.76 0.25 6.39 9.40 13.52 17.56 20.03
Dividend Payout % 51% 68% 63% 65% 52% 0% 0% 39% 32% 33% 26% 20%

(S): Standalone figures, shown where consolidated figures are not available.

Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Equity Capital 92 92 92 92 92 92 92 92 92 92 92 92 92
Reserves 103 132 139 141 152 176 181 234 288 386 505 649 723
50 52 67 66 21 4 3 5 2 34 33 37 35
196 185 160 134 157 177 157 131 173 212 222 214 269
Total Liabilities 442 460 458 432 422 449 432 462 555 723 852 991 1,118
286 301 296 294 280 303 283 277 275 347 328 365 387
CWIP 3 3 0 0 1 0 3 0 3 0 33 3 3
Investments 0 0 0 0 0 0 0 0 0 0 0 0 142
153 157 163 138 141 146 145 185 278 376 491 624 586
Total Assets 442 460 458 432 422 449 432 462 555 723 852 991 1,118

(S): Standalone figures, shown where consolidated figures are not available.

Cash Flows

Figures in Rs. Crores

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
64 62 28 48 75 86 27 94 144 200 157 167
-29 -33 -22 -30 -17 -40 -19 -74 -108 -158 -111 -178
-35 -30 -5 -17 -44 -43 -3 -3 -26 -32 -46 -46
Net Cash Flow -0 -0 -0 1 14 4 5 17 11 9 -0 -57
Free Cash Flow 35 29 5 17 58 46 6 65 100 131 120 108
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 98% 104% 57% 82% 110% 113% 88% 95% 102% 127% 89% 88%

(S): Standalone figures, shown where consolidated figures are not available.

Ratios

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Debtor Days 40 41 47 41 35 35 40 18 23 17 20 28
Inventory Days
Days Payable
Cash Conversion Cycle 40 41 47 41 35 35 40 18 23 17 20 28
Working Capital Days -35 -22 -17 -7 -5 -10 -1 -2 -12 -24 -19 -4
ROCE % 23% 18% 17% 15% 19% 21% 3% 29% 34% 38% 39% 36%

(S): Standalone figures, shown where consolidated figures are not available.

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Average Length of Stay (ALOS)
days ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Discharges (Inpatient Volumes)
count ・Standalone data
Out-patients (OPD Visits)
count ・Standalone data
Revenue per Bed Day (ARPOB)
Rs. ・Standalone data
Revenue per Patient
Rs. ・Standalone data
Bed Occupancy Rate
% ・Standalone data
Total Operational Beds
beds ・Standalone data
International Patients Share of Revenue
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00%
0.95% 1.08% 1.70% 2.64% 2.88% 2.94% 2.73% 2.41% 2.72% 2.43% 2.77% 2.39%
6.36% 4.91% 3.14% 3.19% 3.18% 3.56% 3.56% 3.51% 0.82% 0.87% 0.59% 1.77%
41.69% 43.01% 44.14% 43.16% 42.91% 42.50% 42.74% 43.08% 45.43% 45.69% 45.65% 44.83%
No. of Shareholders 51,44854,15855,10364,67169,69770,49170,21170,91471,22572,98075,09877,706

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents